Smart Reporting’s €23M Series C Funding Boosts AI-powered Medical Software

  • Munich’s Smart Reporting secures €23 million in Series C funding, totaling over €60 million in funding.
  • Founded in 2014 as a spin-off from LMU, Smart Reporting focuses on efficient medical reporting amid a decreasing number of radiologists.
  • Their “SmartReports” software offers voice-controlled, data-driven documentation for radiology and pathology, automating routine tasks and ensuring consistency.
  • The rise of generative AI presents new opportunities for reporting efficiency, reducing work overload and supporting doctors with effective assistance systems.
  • Strategic partnerships with major healthcare IT players like Siemens Healthineers, GE Healthcare, and Canon, along with a collaboration with Solventum in 2023, strengthen Smart Reporting’s international presence.
  • TVM Capital Life Science leads the investment, highlighting Smart Reporting’s potential to become a global leader in radiology and pathology.

Main AI News:

Smart Reporting, a Munich-based healthtech firm, has successfully closed a Series C funding round, securing a substantial €23 million. This latest round of financing elevates the company’s total funding to over €60 million. Established in 2014 as a spin-off from Ludwig-Maximilians-Universität (LMU), Smart Reporting has been at the forefront of revolutionizing medical reporting.

In today’s landscape, where the number of radiologists is dwindling, the need for efficient medical reporting has never been more critical. Smart Reporting recognized this challenge early on and developed cutting-edge, manufacturer-agnostic medical software tailored for fields like radiology and pathology. Their flagship product, “SmartReports,” offers a comprehensive solution for doctors, featuring fully voice-controlled and data-driven documentation capabilities. This not only streamlines workflow but also ensures consistency by automating routine tasks.

The advent of generative AI has further accelerated opportunities for enhancing reporting efficiency in radiology and pathology. This technological advancement not only alleviates work overload but also provides invaluable support to medical professionals through effective assistance systems.

Smart Reporting’s software has gained widespread international recognition and adoption, thanks to strategic partnerships with major healthcare IT players such as Siemens Healthineers, GE Healthcare, and Canon. Moreover, the company’s collaboration with Solventum (formerly 3M Health Information Systems) in 2023 bolstered its foothold in North America’s radiological reporting market.

Professor Dr. Wieland Sommer, co-founder and co-CEO of Smart Reporting, expressed his satisfaction with the successful funding round, emphasizing the company’s commitment to international expansion. With a recent market entry into the USA, Smart Reporting aims to penetrate key global healthcare IT markets and further develop AI-based solutions.

Leading the investment is TVM Capital Life Science, joined by Bayern Kapital and existing investors. Dr. Hubert Birner, Managing Partner at TVM Capital Life Science in Germany, underscored Smart Reporting’s potential to emerge as a global leader in radiology and pathology, praising its focus on industry partnerships for sales.

Stefan Fischer, Managing Partner at TVM Capital Life Science, emphasized the alignment of Smart Reporting with their investment strategy, which prioritizes companies with differentiated business models that directly benefit patients. The influx of capital will fuel product development and international partnerships, particularly in the US, Canadian, Australian, and New Zealand markets. Additionally, Smart Reporting will augment its management team to support its ambitious international growth strategy.

In the forthcoming months, Smart Reporting is poised to expand its global footprint and enrich its product portfolio with additional LLM services, cementing its position as a frontrunner in AI-powered medical software.


Smart Reporting’s successful Series C funding round and strategic partnerships signal a significant advancement in AI-powered medical software development. With the influx of capital, the company is poised to further expand its presence in key global healthcare IT markets, driving innovation and efficiency in radiology and pathology reporting. This underscores a growing demand for technology-driven solutions to address challenges in the healthcare industry.